These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 22347514)

  • 41. Risk Factors Associated with Human Visceral Leishmaniasis in an Urban Area of Bahia, Brazil.
    Maia Z; Viana V; Muniz E; Gonçalves LO; Mendes CM; Mehta SR; Badaro R
    Vector Borne Zoonotic Dis; 2016 Jun; 16(6):368-76. PubMed ID: 27074100
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An emerging peri-urban pattern of infection with Leishmania chagasi, the protozoan causing visceral leishmaniasis in northeast Brazil.
    Jeronimo SM; Duggal P; Braz RF; Cheng C; Monteiro GR; Nascimento ET; Martins DR; Karplus TM; Ximenes MF; Oliveira CC; Pinheiro VG; Pereira W; Peralta JM; Sousa J; Medeiros IM; Pearsoni RD; Burns TL; Pugh EW; Wilson ME
    Scand J Infect Dis; 2004; 36(6-7):443-9. PubMed ID: 15307565
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Visceral leishmaniasis in children: a cohort of 120 patients in a metropolitan city of Brazil.
    Rocha NA; Silva GB; Oliveira MJ; Abreu KL; Franco LF; Silva MP; Garcia AV; Daher EF
    Turk J Pediatr; 2011; 53(2):154-60. PubMed ID: 21853652
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical aspects of visceral leishmaniasis caused by L. infantum in adults. Ten years of experience of the largest outbreak in Europe: what have we learned?
    Horrillo L; Castro A; Matía B; Molina L; García-Martínez J; Jaqueti J; García-Arata I; Carrillo E; Moreno J; Ruiz-Giardin JM; San Martín J
    Parasit Vectors; 2019 Jul; 12(1):359. PubMed ID: 31340851
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Development of a Multiplexed Assay for Detection of
    Abeijon C; Alves F; Monnerat S; Wasunna M; Mbui J; Viana AG; Bueno LL; Siqueira WF; Carvalho SG; Agrawal N; Fujiwara R; Sundar S; Campos-Neto A
    J Clin Microbiol; 2019 May; 57(5):. PubMed ID: 30787142
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of rK39 testing in guiding treatment initiation and outcome in patients with visceral leishmaniasis in Ethiopia: A prospective cohort study.
    Hagos DG; Kebede Y; Abdulkader M; Nigus E; Gessesse Arefaine Z; Nega G; Schallig HDF; Wolday D
    PLoS One; 2021; 16(6):e0253303. PubMed ID: 34125865
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Historical series of patients with visceral leishmaniasis treated with meglumine antimoniate in a hospital for tropical diseases, Maceió-AL, Brazil.
    Silveira LJ; Rocha TJ; Ribeiro SA; Pedrosa CM
    Rev Inst Med Trop Sao Paulo; 2015; 57(1):33-8. PubMed ID: 25651324
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Visceral leishmaniasis treatment outcome and its determinants in northwest Ethiopia.
    Welay GM; Alene KA; Dachew BA
    Epidemiol Health; 2016; 39():e2017001. PubMed ID: 28092934
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Risk factors for visceral leishmaniasis relapse in immunocompetent patients following treatment with 20 mg/kg liposomal amphotericin B (Ambisome) in Bihar, India.
    Burza S; Sinha PK; Mahajan R; Lima MA; Mitra G; Verma N; Balasegaram M; Das P
    PLoS Negl Trop Dis; 2014; 8(1):e2536. PubMed ID: 24392166
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Epidemiological profile and lethality of visceral leishmaniasis/human immunodeficiency virus co-infection in an endemic area in Northeast Brazil.
    Machado CAL; Sevá ADP; Silva AAFAE; Horta MC
    Rev Soc Bras Med Trop; 2021; 54():e0795. PubMed ID: 33886819
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Longitudinal evaluation of asymptomatic Leishmania infection in HIV-infected individuals in North-West Ethiopia: A pilot study.
    van Griensven J; van Henten S; Mengesha B; Kassa M; Adem E; Endris Seid M; Abdellati S; Asefa W; Simegn T; Debasu D; Bogale T; Gedamu Y; Van Den Bossche D; Adriaensen W; Van der Auwera G; Cnops L; Vogt F; Diro E
    PLoS Negl Trop Dis; 2019 Oct; 13(10):e0007765. PubMed ID: 31593563
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Epidemiological profile of patients co-infected with visceral leishmaniasis and HIV/AIDS in Northeast, Brazil.
    Viana GMC; Silva MACND; Garcia JVS; Guimarães HD; Arcos GF; Santos AVA; Paixão PVD; Nascimento MDDSB; Galvão CS
    Rev Soc Bras Med Trop; 2017; 50(5):613-620. PubMed ID: 29160507
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterization of visceral leishmaniasis outbreak, Marsabit County, Kenya, 2014.
    Kanyina EW
    BMC Public Health; 2020 Apr; 20(1):446. PubMed ID: 32248804
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Validation of two rapid diagnostic tests for visceral leishmaniasis in Kenya.
    Mbui J; Wasunna M; Balasegaram M; Laussermayer A; Juma R; Njenga SN; Kirigi G; Riongoita M; de la Tour R; van Peteghem J; Omollo R; Chappuis F
    PLoS Negl Trop Dis; 2013; 7(9):e2441. PubMed ID: 24086782
    [TBL] [Abstract][Full Text] [Related]  

  • 55. High levels of anti-Leishmania IgG3 and low CD4
    Kuschnir RC; Pereira LS; Dutra MRT; de Paula L; Silva-Freitas ML; Corrêa-Castro G; da Costa Cruz Silva S; Cota G; Santos-Oliveira JR; Da-Cruz AM
    BMC Infect Dis; 2021 Apr; 21(1):369. PubMed ID: 33874901
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Visceral leishmaniasis and leishmaniasis-HIV coinfection: comparative study.
    Coutinho JVSC; Santos FSD; Ribeiro RDSP; Oliveira IBB; Dantas VB; Santos ABFS; Tauhata JR
    Rev Soc Bras Med Trop; 2017; 50(5):670-674. PubMed ID: 29160515
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The emergence of concurrent HIV-1/AIDS and visceral leishmaniasis in Northeast Brazil.
    Nascimento ET; Moura ML; Queiroz JW; Barroso AW; Araujo AF; Rego EF; Wilson ME; Pearson RD; Jeronimo SM
    Trans R Soc Trop Med Hyg; 2011 May; 105(5):298-300. PubMed ID: 21474157
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Concomitant malaria among visceral leishmaniasis in-patients from Gedarif and Sennar States, Sudan: a retrospective case-control study.
    van den Bogaart E; Berkhout MM; Nour AB; Mens PF; Talha AB; Adams ER; Ahmed HB; Abdelrahman SH; Ritmeijer K; Nour BY; Schallig HD
    BMC Public Health; 2013 Apr; 13():332. PubMed ID: 23577673
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Parasite load and risk factors for poor outcome among children with visceral leishmaniasis. A cohort study in Belo Horizonte, Brazil, 2010-2011.
    Mourão MV; Toledo A; Gomes LI; Freire VV; Rabello A
    Mem Inst Oswaldo Cruz; 2014 Apr; 109(2):147-53. PubMed ID: 24676657
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prediction of visceral leishmaniasis incidence using the Seasonal Autoregressive Integrated Moving Average model (SARIMA) in the state of Maranhão, Brazil.
    Pimentel KBA; Oliveira RS; Aragão CF; Aquino Júnior J; Moura MES; Guimarães-E-Silva AS; Pinheiro VCS; Gonçalves EGR; Silva AR
    Braz J Biol; 2022; 84():e257402. PubMed ID: 35081217
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.